PATH was commissioned by Crucell to improve understanding of the impact on health care waste management of a new presentation of liquid pentavalent vaccine targeted for use in developing countries. This report details the findings of a quantitative and qualitative analysis PATH conducted on the differences between delivery of Quinvaxem® in the Uniject™ injection system and delivery in a vial using a syringe.